Ora Strengthens Global Leadership with Key Appointments in Europe and People Services
22.10.2024 14:00:00 CEST | Business Wire | Press release
Ora, the leading global ophthalmic contract research organization (CRO), is pleased to announce the appointments of Marcin Ernst, MD, MBA, as Vice President of Europe, and Tim Neathery as Chief People Officer. These strategic additions come as Ora intensifies its commitment to scaling global operations and attracting top talent to deliver unparalleled services to ophthalmic innovators worldwide.
Paul Colvin, Chief Executive Officer at Ora, commented: “At Ora, our therapeutic focus, global reach, and exceptional team members drive high-quality clinical trials and programs essential for efficient product development. Dr Marcin Ernst and Tim Neathery bring extensive experience in building high-performing teams and fostering talent development. Their leadership will reinforce our commitment to cultivating our people and providing unmatched operational excellence to our clients across the globe.”
In his new role as Vice President of Europe, Dr Marcin Ernst will leverage his strategic insight and proven track record in clinical development to expand Ora’s footprint in Europe and oversee global clinical development programs. Marcin brings invaluable expertise in managing expansive global business units across Europe and Latin America, including previous leadership roles at INC Research® and Syneos® Health where he served as Executive Vice President and General Manager. With over two decades of experience in CRO leadership including management of large-scale clinical trials, Marcin brings a unique blend of clinical insight and business acumen to his role at Ora. His prior experience as a general and cardiac surgeon further enhances his ability to navigate complex challenges in the industry. This combination positions him to drive Ora's continued global success and make a lasting impact in the field.
As Chief People Officer, Tim Neathery will play a pivotal role in enhancing Ora’s organizational culture and driving talent development initiatives. With over 25 years of experience in the clinical research sector, Tim is celebrated for implementing best-in-class recruitment and retention strategies. His impressive background includes leadership at Javara Research as Chief People & Technology Officer, where he revolutionized HR practices and led technological advancements that supported company growth. Additionally, as Senior Vice President at PPDtm, he globalized the Talent Acquisition function and initiated transformative programs that significantly boosted employee engagement and retention. Tim’s visionary leadership and strategic insight will be key to fostering a thriving workplace culture at Ora.
About Ora
Ora is the world’s leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, and Asia-Pacific. For over 45 years, we have proudly helped our clients earn more than 85 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora’s clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world’s most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives. For more information, please visit www.oraclinical.com and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241022297296/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LR Health & Beauty SE Successfully Completes Financial Realignment – Strong Foundation for Growth and Long-Term Partnerships25.6.2026 09:00:00 CEST | Press release
Successful completion of the financial realignment enables full focus on growth and further strengthening operational excellence Planned investments in production and logistics will enhance efficiency, flexibility, and delivery capabilities Further international growth, including expansion into new markets, targeted LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has successfully completed its financial realignment, establishing the foundation for the company’s stable and forward-looking development. With the achievement of the final milestone, an intensive and demanding process has been successfully concluded. LR has fundamentally realigned its financing structure and significantly strengthened its capital base. An initial financing tranche of EUR 10 million was provided at the end of March, followed by a second tranche of the same amount in June. Jörg Körfer, CEO of LR Health & Beauty SE, comments: “The pas
YesWeHack Launches Agentic Pentest for AI Security Testing25.6.2026 09:00:00 CEST | Press release
New on-demand solution rapidly tests attack surfaces and centralises findings within YesWeHack’s offensive security platform YesWeHack, the offensive security and exposure management platform, announces Agentic Pentest, an on-demand solution using autonomous AI agents to test organisations' assets and deliver same-day findings. Shaped by YesWeHack’s extensive offensive security experience, Agentic Pentest helps organisations identify vulnerabilities, test their real-world exploitability and uncover attack paths across in-scope assets. The solution supports black box, grey box and white box testing of web applications, mobile apps, APIs and other internet-facing assets. YesWeHack, leader in offensive security in Europe and APAC, leverages the best available frontier models for offensive testing, including open-weight models. This flexible approach enables organisations to use models developed and/or hosted anywhere in the world, such as in EU or APAC. Agents operate within guardrails de
H2SITE Secures New Strategic Investment to Accelerate Industrial Deployment of Hydrogen Production and Separation Solutions25.6.2026 06:00:00 CEST | Press release
H2SITE, a leading industrial company in hydrogen production and separation solutions, has completed a second closing of its Series B round. The transaction brings in EIC Fund with a private investor who will support the company’s next phase of growth and increases H2SITE’s total funding raised in this round to more than €42 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624444396/en/ H2SITE These new partners, join BEV, Suma Capital, Hy24, Crane, Enagás Emprende, Calderion and CRPV who participated in the first closing, further validating the confidence of the European innovation ecosystem in H2SITE’s ability to industrialize and deploy key hydrogen solutions at commercial scale. Over the past years, H2SITE has successfully demonstrated the maturity and scalability of its technology, achieving more than 50,000 operating hours with its membrane reactors and separators, establishing advanced manufacturing capabilit
FPT Expands Strategic Collaboration with Microsoft to Advance AI Frontier Innovation Across Asia25.6.2026 04:00:00 CEST | Press release
FPT Corporation today announced an expanded strategic collaboration with Microsoft aimed at accelerating enterprise AI adoption and co‑innovation across Asia, with a strong focus on ASEAN, Japan, and South Korea. The collaboration brings together Microsoft’s global AI platforms with FPT’s large‑scale delivery and regional market capabilities to support organizations as they move from AI experimentation to real‑world, scalable impact, with measurable business outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624200416/en/ Representatives of FPT and Microsoft at the signing ceremony, formalizing an expanded strategic collaboration to advance AI Frontier innovation across Asia The collaboration aligns with FPT’s AI‑First strategy and Microsoft’s vision for human‑agent collaboration, with the goal of enabling enterprises to redesign how work is done across engineering, operations, and business functions. Positioning FP
Murata Expands Product Information Management API Service to Cover All 73 Product Categories25.6.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) now covers all 73 product categories in its Product Information Management (PIM) API Service. By using this API service, engineers, developers, and procurement specialists can retrieve up-to-date product information, enabling prompt responses to product status changes and reducing the risk of component obsolescence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624146819/en/ [Murata Manufacturing Co., Ltd.] Murata expands Product Information Management API Service to cover all 73 product categories As digital transformation accelerates in the manufacturing industry, a wide variety of systems and platforms are being used across the entire workflow - from design and component selection through to procurement. Previously, Murata’s PIM API Service covered only surface-mount and leaded ceramic capacitors and inductors. This narrow service coverage required user
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom